Meet us at the European Association of Cancer Research (EACR) 2025 Congress: Innovative Cancer Science, in Lisbon Congress Centre, Lisbon, Portugal, from June 16^th – 19^th, 2025, and visit our work at the poster session „Tumor Biology” where will be presented our collaborative research about targeting tumor hypoxia and immunoblockade to improve breast cancer therapy, which findings highlight that co-targeting HIF-1 and PD-L1 could enhance breast cancer therapy by improving immune checkpoint inhibitors efficacy. (Poster number: P-692; Abstract Number: EACR25-2214; Time of presentation: 17^th of June 2025 from 10:45 to 20:00).

Poster abstract link (in the pdf form, abstract number is EACR25-2214 on page 795):

The publication can be accessed under the following link.